Search Reset All ProductsExchange ProfilesHealth Plan AnalysisHealth Plan Data & AnalysisMarket OverviewNational MCO AnalyzerNational MCO Analyzer Series All StatesAlabamaAlaskaArizonaArkansasCaliforniaColoradoConnecticutDelawareDistrict of ColumbiaFloridaGeorgiaHawaiiIdahoIllinoisIndianaIowaKansasKentuckyLouisianaMaineMarylandMassachusettsMichiganMinnesotaMississippiMissouriMontanaNebraskaNevadaNew HampshireNew JerseyNew MexicoNew YorkNorth CarolinaNorth DakotaOhioOklahomaOregonPennsylvaniaPuerto RicoRhode IslandSouth CarolinaSouth DakotaStateTennesseeTexasUtahVermontVirginiaWashingtonWest VirginiaWisconsinWyoming All Years2024202320202019201820172016201520142012201120102009 Previous1...101112 January 14, 2010 Pharmacy Benefit Evaluator 2.0 | Data | January 2010 December 30, 2009 Formulary Advantages in Chronic Pain Therapies: How Will Price Impact the Coverage of Expensive Abuse-Deterrent Opioids and Biologics? Chronic pain is a multi-billion dollar market saturated with well-established branded and generic analgesics that are only partially effective. While drugs with novel mechanisms of action that offer g… July 22, 2009 Pharmacy Benefit Evaluator 2.0 | Data | July 2009 Previous1...101112